Cardiology Training

PART 1: Building the New ACC/AHA Guidelines

Dr. Hector Michelena (Mayo Clinic) & Special Guest: Dr. Robert O. Bonow (Northwestern University)

PART 2: Detecting the Leak: Multimodality Imaging Evaluation of Aortic Regurgitation

Dr. Hector Michelena & Dr. Jeremy D. Collins (Mayo Clinic)

PART 3: Bicuspid Aortic Valve – New Nomenclature & Growing Role of Valve Repair

Dr. Hector Michelena, Dr. Marc Gerdisch (Franciscan Health) & Dr. Joshua Baker (Missouri Baptist)

NEW International BAV Classification Growth of Valve Repair

Presenter: Dr. Hector Michelena (Mayo Clinic) & Special Guest: Dr. Robert O. Bonow (Northwestern University)

Building the new ACC/AHA guidelines from critical concepts on pathophysiology, physical exam and echocardiography.

Objectives:

  • Etiology, mechanisms and pathophysiology of chronic aortic regurgitation
  • Importance of physical examination for the diagnosis and prognostication of chronic aortic valve regurgitation
  • The comprehensive echocardiographic diagnostic assessment, including echocardiographic surveillance timing
  • Established and new echocardiographic prognosticators in chronic aortic regurgitation

Detecting the Leak: Multimodality-imaging evaluation of AR

Dr. Hector Michelena & Dr. Jeremy D. Collins, MD, FSIR (Mayo Clinic)

Dr. Jeremy Collins and Dr. Hector Michelena explore 4D Flow and advanced visualization features that are transforming AR detection. These new tools quickly and easily quantify and visualize flow anywhere in the heart. Dr. Collins and Dr. Michelena will lead a case-based discussion highlighting when these new techniques are critical and how to operationalize them.

NEW International BAV Classification & Growth of Valve Repair

Dr. Hector Michelena, Dr. Marc Gerdisch (Franciscan Health) & Dr. Joshua Baker (Missouri Baptist)

Bicuspid aortic valve disease is the most prevalent congenital heart disease, and a challenging aspect of BAV management is the wide variability of phenotypic expressions. This range highlights the importance of a consistent, comprehensive, and straightforward approach for describing this variability. Dr. Michelena will review the new international consensus statement on BAV nomenclature.

For the young BAV patient, new advancements in aortic valve repair are providing significant benefits of improved durability and freedom from lifelong anticoagulation therapy. However, the heterogeneity of BAV presentation similar presents challenges for repair. Dr. Marc Gerdisch and Dr. Joshua Baker review advances in valve repair for the many forms of BAV and AR presentation.

Subscribe for updates on future webinars and training